BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 20545696)

  • 1. Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma.
    Hasita H; Komohara Y; Okabe H; Masuda T; Ohnishi K; Lei XF; Beppu T; Baba H; Takeya M
    Cancer Sci; 2010 Aug; 101(8):1913-9. PubMed ID: 20545696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18/STAT3 pathway.
    Zhou M; Yu H; Bai M; Lu S; Wang C; Ke S; Huang J; Li Z; Xu Y; Yin B; Li X; Feng Z; Fu Y; Jiang H; Ma Y
    Cancer Sci; 2024 Mar; 115(3):777-790. PubMed ID: 38228495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of transforming growth factor-beta1 on human intrahepatic cholangiocarcinoma cell growth.
    Shimizu T; Yokomuro S; Mizuguchi Y; Kawahigashi Y; Arima Y; Taniai N; Mamada Y; Yoshida H; Akimaru K; Tajiri T
    World J Gastroenterol; 2006 Oct; 12(39):6316-24. PubMed ID: 17072955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3.
    Zhou Z; Wang P; Sun R; Li J; Hu Z; Xin H; Luo C; Zhou J; Fan J; Zhou S
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33692217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma.
    Komohara Y; Hasita H; Ohnishi K; Fujiwara Y; Suzu S; Eto M; Takeya M
    Cancer Sci; 2011 Jul; 102(7):1424-31. PubMed ID: 21453387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
    Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
    Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M2 macrophage/microglial cells induce activation of Stat3 in primary central nervous system lymphoma.
    Komohara Y; Horlad H; Ohnishi K; Ohta K; Makino K; Hondo H; Yamanaka R; Kajiwara K; Saito T; Kuratsu J; Takeya M
    J Clin Exp Hematop; 2011; 51(2):93-9. PubMed ID: 22104307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1.
    Jing CY; Fu YP; Yi Y; Zhang MX; Zheng SS; Huang JL; Gan W; Xu X; Lin JJ; Zhang J; Qiu SJ; Zhang BH
    J Immunother Cancer; 2019 Mar; 7(1):77. PubMed ID: 30885276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 inhibition specifically in human monocytes and macrophages by CD163-targeted corosolic acid-containing liposomes.
    Andersen MN; Etzerodt A; Graversen JH; Holthof LC; Moestrup SK; Hokland M; Møller HJ
    Cancer Immunol Immunother; 2019 Mar; 68(3):489-502. PubMed ID: 30637473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated CD163
    Yang C; Wei C; Wang S; Shi D; Zhang C; Lin X; Dou R; Xiong B
    Int J Biol Sci; 2019; 15(5):984-998. PubMed ID: 31182919
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical significance of CD163⁺ tumor-associated macrophages in patients with adult T-cell leukemia/lymphoma.
    Komohara Y; Niino D; Saito Y; Ohnishi K; Horlad H; Ohshima K; Takeya M
    Cancer Sci; 2013 Jul; 104(7):945-51. PubMed ID: 23557330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma.
    Sun BY; Yang ZF; Wang ZT; Liu G; Zhou C; Zhou J; Fan J; Gan W; Yi Y; Qiu SJ
    World J Surg Oncol; 2023 Mar; 21(1):90. PubMed ID: 36899373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6-induced cGGNBP2 encodes a protein to promote cell growth and metastasis in intrahepatic cholangiocarcinoma.
    Li H; Lan T; Liu H; Liu C; Dai J; Xu L; Cai Y; Hou G; Xie K; Liao M; Li J; Huang J; Yuan K; Wang G; Zeng Y; Wu H
    Hepatology; 2022 Jun; 75(6):1402-1419. PubMed ID: 34758510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma.
    Kim KJ; Wen XY; Yang HK; Kim WH; Kang GH
    PLoS One; 2015; 10(12):e0144192. PubMed ID: 26714314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages.
    Raggi C; Correnti M; Sica A; Andersen JB; Cardinale V; Alvaro D; Chiorino G; Forti E; Glaser S; Alpini G; Destro A; Sozio F; Di Tommaso L; Roncalli M; Banales JM; Coulouarn C; Bujanda L; Torzilli G; Invernizzi P
    J Hepatol; 2017 Jan; 66(1):102-115. PubMed ID: 27593106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3 is over-activated within CD163
    Andersen MN; Andersen NF; Lauridsen KL; Etzerodt A; Sorensen BS; Abildgaard N; Plesner T; Hokland M; Møller HJ
    Cancer Immunol Immunother; 2022 Jan; 71(1):177-187. PubMed ID: 34061243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apatinib Inhibits Angiogenesis in Intrahepatic Cholangiocarcinoma by Regulating the Vascular Endothelial Growth Factor Receptor-2/Signal Transducer and Activator of Transcription Factor 3/Hypoxia Inducible Factor 1 Subunit Alpha Signaling Axis.
    Huang MP; Gu SZ; Huang B; Li GW; Xiong ZP; Tang T; Zeng SN
    Pharmacology; 2021; 106(9-10):509-519. PubMed ID: 34412054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer.
    Lan C; Huang X; Lin S; Huang H; Cai Q; Wan T; Lu J; Liu J
    Technol Cancer Res Treat; 2013 Jun; 12(3):259-67. PubMed ID: 23289476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M2-polarized tumor-associated macrophages promote epithelial-mesenchymal transition via activation of the AKT3/PRAS40 signaling pathway in intrahepatic cholangiocarcinoma.
    Sun D; Luo T; Dong P; Zhang N; Chen J; Zhang S; Dong L; Janssen HLA; Zhang S
    J Cell Biochem; 2020 Apr; 121(4):2828-2838. PubMed ID: 31692069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of FOXP3 inhibits invasion and immune escape in cholangiocarcinoma.
    Ma C; Peng C; Lu X; Ding X; Zhang S; Zou X; Zhang X
    Biochem Biophys Res Commun; 2015 Mar; 458(2):234-9. PubMed ID: 25623530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.